Relmada Therapeutics (RLMD) Depreciation & Amortization (CF) (2014 - 2021)
Relmada Therapeutics (RLMD) posted Depreciation & Amortization (CF) of $1,258 for FY2021, down 66.5% from $3,752 in FY2020.
Powered by 
Analysis
Relmada Therapeutics (RLMD) Depreciation & Amortization (CF) (2014 - 2021) Analysis & Trends
Since FY2013, Relmada Therapeutics has reported Depreciation & Amortization (CF) for 9 years.
- Annual Depreciation & Amortization (CF) shows a five-year compound annual growth rate of -53.0% (FY2016 to FY2021).
- The FY2021 figure stands as the lowest annual Depreciation & Amortization (CF) since FY2013.
- Business Quant data shows RLMD's Depreciation & Amortization (CF) at $3,752 in FY2020 (-14.0%), $4,363 in FY2019, $2,627 in FY2018 (-96.9%) and $85,271 in FY2017 (+55.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.96 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 194.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 599.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.93 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.11 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 98.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 1.62 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 56.50 Mn |
| 10 | Relmada Therapeutics | 402.15 Mn | 402.15 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2021 | -1.30 Mn |
| Jun 30, 2021 | 452.00 |
| Mar 31, 2021 | 806.00 |
| Dec 31, 2020 | 823.00 |
| Sep 30, 2020 | -2.10 Mn |
| Jun 30, 2020 | 1,029.00 |
| Mar 31, 2020 | 1,046.00 |
| Dec 31, 2019 | -1,582.00 |
| Sep 30, 2019 | 1,100.00 |
| Mar 31, 2019 | 1,075.00 |
| Dec 31, 2018 | 1,607.00 |
| Sep 30, 2018 | 1,405.00 |
| Jun 30, 2018 | 929.00 |
| Mar 31, 2018 | 568.00 |
| Dec 31, 2017 | 582.00 |
| Sep 30, 2017 | 548.00 |
| Jun 30, 2017 | 18,259.00 |
| Mar 31, 2017 | 23,268.00 |
| Dec 31, 2016 | 23,581.00 |
| Sep 30, 2016 | 20,163.00 |
API Access
Relmada Therapeutics Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=RLMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "RLMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=RLMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();